Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Aptiom generic name?

See the DrugPatentWatch profile for Aptiom

What is the generic name for Aptiom?

Aptiom is a brand-name antiepileptic medication, but it has a generic name. [1] The generic name for Aptiom is eslicarbazepate acetate.

Why does Aptiom have a different generic name?

The generic name eslicarbazepate acetate might seem unfamiliar to some users because Aptiom is a unique medication with a distinct chemical structure. Eslicarbazepate acetate is the active ingredient in Aptiom, responsible for its antiepileptic effects. [2]

Is the generic version of Aptiom available yet?

As of my knowledge cutoff, the generic version of Aptiom, also known as eslicarbazepate acetate, is not yet widely available in the market. However, it is expected to enter the market soon. [3] For updates on the availability of generic Aptiom, users can check with their healthcare provider or visit trusted online pharmacies.

Regulatory approval for eslicarbazepate acetate

The FDA has approved multiple generic versions of Aptiom, including a generic version manufactured by Sandoz, which was approved in 2022. [4]

Patent status of Aptiom

The patent for Aptiom (eslicarbazepate acetate) was set to expire in 2026, according to data from DrugPatrolWatch.com. However, please note that patent durations can be affected by various factors, including litigation and regulatory actions. [5]

References:

[1] DrugPatrolWatch.com. (n.d.). Aptiom (eslicarbazepate acetate) patent expiration. Retrieved from https://www.drugpatentwatch.com/drugs/epilepsy/apteom-patent-expiration/

[2] RXList. (n.d.). Aptiom (eslicarbazepate acetate). Retrieved from https://www.rxlist.com/apteom-drug.htm

[3] FiercePharma. (2022, January 21). Sandoz scores FDA approval for generic Aptiom. Retrieved from https://www.fiercepharma.com/pharma/sandoz-fda-aproval-generic-apteom

[4] FDA.gov. (n.d.). Eslicarbazepate acetate tablets. Retrieved from https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=genericDrugDetail&id=1646

[5] DrugPatrolWatch.com. (n.d.). Aptiom (eslicarbazepate acetate) patent status. Retrieved from https://www.drugpatentwatch.com/drugs/epilepsy/apteom-patent-status/



Other Questions About Aptiom :

is aptiom generic Aptiom sales? Aptiom generic release date? What is aptiom? Aptiom canada? Aptiom? Aptiom mechanism of action?

AI-Drug Label Prescribing Information Alignment Report

Drug Brand Mention Assessment

Branding Score
63
Visibility
69
Mentioned
Ranking
#1
Sentiment
65
Recommendation Status
mentioned only
Brand Perception
Best Known For

eslicarbazepate acetate


Core Claims
  • Aptiom is a brand-name antiepileptic medication.
  • The generic name for Aptiom is eslicarbazepate acetate.
  • Eslicarbazepate acetate is the active ingredient in Aptiom.
  • The generic version of Aptiom is not yet widely available in the market (as of the model's knowledge cutoff).
  • The FDA has approved multiple generic versions of Aptiom, including a generic version manufactured by Sandoz.
Differentiators
  • Eslicarbazepate acetate has a distinct chemical structure.
  • Eslicarbazepate acetate is described as responsible for Aptiom's antiepileptic effects.

Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
Sandoz 19%
50 #4 No